Clinical trial Recruiting at 1 site Phase 3 Interventional Ages 18 and up

Comparing two mixtures of propofol and etomidate for anesthesia during endoscopic procedures

Official title: Propofol and Etomidate Admixtures Comparisons Trial (PEAC Trial)

Run by University of Texas Southwestern Medical Center · NCT05358535 · Data updated 2026-11-12

This study is testing two different mixtures of anesthesia to see which one works better for keeping patients stable and minimizing side effects during endoscopic procedures.

Quick facts

PhasePhase 3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment200 (estimated)
SponsorUniversity of Texas Southwestern Medical Center
Academic / other
Locations1 site (Dallas, Texas)
StatusRecruiting
StartedSeptember 19, 2022
Main results expectedJanuary 2027
Study endsMarch 2027
Registry record updatedJanuary 20, 2026
Trial IDNCT05358535 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adult patients aged 18 and older who are scheduled for an endoscopic procedure at Clements University Hospital and have an ASA classification of 3 or above.

Probably not a fit

Patients with known allergies to the study drugs, those who refuse participation, or individuals with cognitive impairments that prevent informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the hemodynamic stability and adverse event profiles of two different admixtures of propofol and etomidate for anesthesia during endoscopic procedures. The study compares a 25% propofol and 75% etomidate mixture (P2E7) against a 75% propofol and 25% etomidate mixture (P7E2) in a randomized controlled double-blind design. It aims to provide insights into which admixture ratio is more effective in minimizing side effects and ensuring stable hemodynamics in patients with compromised cardiopulmonary status. The trial is conducted at the Clements University Hospital endoscopy lab, focusing on adult patients undergoing gastrointestinal endoscopy.

Why it matters

Potential benefit: If successful, this study could lead to safer anesthesia practices for patients undergoing endoscopic procedures, particularly those with compromised health.

How similar studies have gone: While there is limited definitive literature on the optimal admixture ratios of propofol and etomidate, this study aims to fill a gap in understanding and may build on previous findings in anesthesia practices.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Adult patients (age ≥18 years old)
2. Having endoscopic procedure at CUH with anesthesia
3. ASA 3 or above
4. Ejection Fraction test result available

Exclusion Criteria:

1. Known allergies or adverse reactions to study drugs or study drug components or preservatives
2. Patient refusal
3. Clinician refusal
4. Documented cognitive impairments precluding subject ability to consent for themselves unless a surrogate documented legally acceptable decision maker consents for patient participation
5. Prisoner or incarcerated or patients held by law enforcement officials in custody
6. Pregnancy or patient refusal for pregnancy testing or screening (standard UTSW policy and protocol requires pregnancy testing for appropriate patients prior to anesthesia)

Where it's running

  • Clements University Hospital
    Dallas, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.